nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ABCB1—colon cancer	0.28	1	CbGaD
Pitavastatin—SLCO1B1—Irinotecan—colon cancer	0.0559	0.0958	CbGbCtD
Pitavastatin—SLCO1B3—Methotrexate—colon cancer	0.0508	0.0871	CbGbCtD
Pitavastatin—ABCC2—Irinotecan—colon cancer	0.0491	0.0842	CbGbCtD
Pitavastatin—ABCG2—Irinotecan—colon cancer	0.0444	0.0761	CbGbCtD
Pitavastatin—ABCC2—Vincristine—colon cancer	0.0429	0.0736	CbGbCtD
Pitavastatin—ABCG2—Fluorouracil—colon cancer	0.0426	0.0731	CbGbCtD
Pitavastatin—ABCG2—Vincristine—colon cancer	0.0388	0.0665	CbGbCtD
Pitavastatin—ALB—Irinotecan—colon cancer	0.0306	0.0525	CbGbCtD
Pitavastatin—SLCO1B1—Methotrexate—colon cancer	0.0296	0.0507	CbGbCtD
Pitavastatin—ALB—Fluorouracil—colon cancer	0.0294	0.0504	CbGbCtD
Pitavastatin—CYP2C9—Capecitabine—colon cancer	0.0267	0.0458	CbGbCtD
Pitavastatin—ABCC2—Methotrexate—colon cancer	0.026	0.0446	CbGbCtD
Pitavastatin—ABCG2—Methotrexate—colon cancer	0.0235	0.0403	CbGbCtD
Pitavastatin—CYP2C8—Fluorouracil—colon cancer	0.0227	0.0389	CbGbCtD
Pitavastatin—ALB—Methotrexate—colon cancer	0.0162	0.0278	CbGbCtD
Pitavastatin—ABCB1—Irinotecan—colon cancer	0.016	0.0274	CbGbCtD
Pitavastatin—CYP2C9—Fluorouracil—colon cancer	0.0158	0.0271	CbGbCtD
Pitavastatin—ABCB1—Vincristine—colon cancer	0.014	0.024	CbGbCtD
Pitavastatin—SLC10A1—bile—colon cancer	0.0123	0.171	CbGeAlD
Pitavastatin—ABCB1—Methotrexate—colon cancer	0.00847	0.0145	CbGbCtD
Pitavastatin—ORM1—bile—colon cancer	0.00754	0.105	CbGeAlD
Pitavastatin—ABCC2—bile—colon cancer	0.0062	0.086	CbGeAlD
Pitavastatin—Memory loss—Fluorouracil—colon cancer	0.00285	0.074	CcSEcCtD
Pitavastatin—HMGCR—gall bladder—colon cancer	0.00237	0.0329	CbGeAlD
Pitavastatin—UGT1A3—digestive system—colon cancer	0.0022	0.0305	CbGeAlD
Pitavastatin—ORM1—gall bladder—colon cancer	0.00209	0.029	CbGeAlD
Pitavastatin—ALB—gall bladder—colon cancer	0.00184	0.0255	CbGeAlD
Pitavastatin—Cognitive impairment—Methotrexate—colon cancer	0.00167	0.0434	CcSEcCtD
Pitavastatin—SLC10A1—renal system—colon cancer	0.00164	0.0228	CbGeAlD
Pitavastatin—UGT1A3—liver—colon cancer	0.00164	0.0227	CbGeAlD
Pitavastatin—UGT2B7—renal system—colon cancer	0.00154	0.0213	CbGeAlD
Pitavastatin—SLCO1B3—vagina—colon cancer	0.00136	0.0189	CbGeAlD
Pitavastatin—SLC10A1—digestive system—colon cancer	0.00135	0.0187	CbGeAlD
Pitavastatin—UGT2B7—digestive system—colon cancer	0.00126	0.0175	CbGeAlD
Pitavastatin—HMGCR—epithelium—colon cancer	0.00123	0.017	CbGeAlD
Pitavastatin—HMGCR—smooth muscle tissue—colon cancer	0.00118	0.0164	CbGeAlD
Pitavastatin—SLCO1B3—liver—colon cancer	0.00115	0.016	CbGeAlD
Pitavastatin—HMGCR—renal system—colon cancer	0.00114	0.0158	CbGeAlD
Pitavastatin—SLCO1B1—renal system—colon cancer	0.00109	0.0151	CbGeAlD
Pitavastatin—Cognitive disorder—Methotrexate—colon cancer	0.00101	0.0262	CcSEcCtD
Pitavastatin—SLC10A1—liver—colon cancer	0.001	0.0139	CbGeAlD
Pitavastatin—SLCO2B1—renal system—colon cancer	0.000963	0.0134	CbGeAlD
Pitavastatin—HMGCR—lymphoid tissue—colon cancer	0.000944	0.0131	CbGeAlD
Pitavastatin—UGT2B7—liver—colon cancer	0.00094	0.013	CbGeAlD
Pitavastatin—HMGCR—digestive system—colon cancer	0.000932	0.0129	CbGeAlD
Pitavastatin—SLCO1B1—digestive system—colon cancer	0.000893	0.0124	CbGeAlD
Pitavastatin—HMGCR—bone marrow—colon cancer	0.000859	0.0119	CbGeAlD
Pitavastatin—ABCC2—renal system—colon cancer	0.000825	0.0114	CbGeAlD
Pitavastatin—HMGCR—vagina—colon cancer	0.000823	0.0114	CbGeAlD
Pitavastatin—SLCO2B1—digestive system—colon cancer	0.00079	0.011	CbGeAlD
Pitavastatin—ORM1—bone marrow—colon cancer	0.000759	0.0105	CbGeAlD
Pitavastatin—Memory impairment—Capecitabine—colon cancer	0.000745	0.0194	CcSEcCtD
Pitavastatin—Hepatic failure—Vincristine—colon cancer	0.000725	0.0188	CcSEcCtD
Pitavastatin—HMGCR—liver—colon cancer	0.000694	0.00963	CbGeAlD
Pitavastatin—Renal failure acute—Irinotecan—colon cancer	0.000687	0.0179	CcSEcCtD
Pitavastatin—ABCC2—digestive system—colon cancer	0.000677	0.00939	CbGeAlD
Pitavastatin—SLCO1B1—liver—colon cancer	0.000665	0.00923	CbGeAlD
Pitavastatin—ABCB1—blood vessel—colon cancer	0.000657	0.00912	CbGeAlD
Pitavastatin—Pain in extremity—Vincristine—colon cancer	0.000652	0.0169	CcSEcCtD
Pitavastatin—Amnesia—Fluorouracil—colon cancer	0.000647	0.0168	CcSEcCtD
Pitavastatin—CYP2C8—renal system—colon cancer	0.000619	0.00859	CbGeAlD
Pitavastatin—Interstitial lung disease—Methotrexate—colon cancer	0.000615	0.016	CcSEcCtD
Pitavastatin—ORM1—liver—colon cancer	0.000614	0.00851	CbGeAlD
Pitavastatin—SLCO2B1—liver—colon cancer	0.000588	0.00816	CbGeAlD
Pitavastatin—Nasopharyngitis—Fluorouracil—colon cancer	0.000543	0.0141	CcSEcCtD
Pitavastatin—ALB—liver—colon cancer	0.000538	0.00747	CbGeAlD
Pitavastatin—HMGCR—lymph node—colon cancer	0.000532	0.00739	CbGeAlD
Pitavastatin—Erectile dysfunction—Vincristine—colon cancer	0.000519	0.0135	CcSEcCtD
Pitavastatin—ABCC2—liver—colon cancer	0.000504	0.007	CbGeAlD
Pitavastatin—Jaundice—Irinotecan—colon cancer	0.000477	0.0124	CcSEcCtD
Pitavastatin—Hepatic failure—Capecitabine—colon cancer	0.000473	0.0123	CcSEcCtD
Pitavastatin—ORM1—lymph node—colon cancer	0.000471	0.00653	CbGeAlD
Pitavastatin—Renal failure acute—Capecitabine—colon cancer	0.00046	0.012	CcSEcCtD
Pitavastatin—ABCG2—bone marrow—colon cancer	0.000455	0.00631	CbGeAlD
Pitavastatin—Amnesia—Capecitabine—colon cancer	0.000452	0.0117	CcSEcCtD
Pitavastatin—SLCO2B1—lymph node—colon cancer	0.000451	0.00626	CbGeAlD
Pitavastatin—CYP2C9—digestive system—colon cancer	0.000451	0.00626	CbGeAlD
Pitavastatin—Hypoaesthesia—Vincristine—colon cancer	0.000448	0.0117	CcSEcCtD
Pitavastatin—CYP2C8—vagina—colon cancer	0.000448	0.00622	CbGeAlD
Pitavastatin—ABCG2—vagina—colon cancer	0.000436	0.00605	CbGeAlD
Pitavastatin—Pain in extremity—Capecitabine—colon cancer	0.000425	0.011	CcSEcCtD
Pitavastatin—Hypoaesthesia—Fluorouracil—colon cancer	0.000418	0.0109	CcSEcCtD
Pitavastatin—ALB—lymph node—colon cancer	0.000413	0.00572	CbGeAlD
Pitavastatin—ABCB1—embryo—colon cancer	0.000392	0.00544	CbGeAlD
Pitavastatin—ABCC2—lymph node—colon cancer	0.000387	0.00536	CbGeAlD
Pitavastatin—Nasopharyngitis—Capecitabine—colon cancer	0.00038	0.00987	CcSEcCtD
Pitavastatin—Back pain—Vincristine—colon cancer	0.00038	0.00987	CcSEcCtD
Pitavastatin—CYP2C8—liver—colon cancer	0.000378	0.00525	CbGeAlD
Pitavastatin—Back pain—Irinotecan—colon cancer	0.00037	0.00961	CcSEcCtD
Pitavastatin—ABCG2—liver—colon cancer	0.000368	0.0051	CbGeAlD
Pitavastatin—Muscle spasms—Irinotecan—colon cancer	0.000367	0.00955	CcSEcCtD
Pitavastatin—Influenza—Capecitabine—colon cancer	0.000367	0.00954	CcSEcCtD
Pitavastatin—Ill-defined disorder—Irinotecan—colon cancer	0.000355	0.00922	CcSEcCtD
Pitavastatin—Abdominal discomfort—Capecitabine—colon cancer	0.000352	0.00915	CcSEcCtD
Pitavastatin—Hepatic failure—Methotrexate—colon cancer	0.000352	0.00914	CcSEcCtD
Pitavastatin—Malaise—Irinotecan—colon cancer	0.000345	0.00896	CcSEcCtD
Pitavastatin—Renal failure acute—Methotrexate—colon cancer	0.000342	0.0089	CcSEcCtD
Pitavastatin—CYP2C9—liver—colon cancer	0.000336	0.00466	CbGeAlD
Pitavastatin—Myalgia—Vincristine—colon cancer	0.000334	0.00868	CcSEcCtD
Pitavastatin—Discomfort—Irinotecan—colon cancer	0.000321	0.00835	CcSEcCtD
Pitavastatin—ABCB1—epithelium—colon cancer	0.00032	0.00444	CbGeAlD
Pitavastatin—Jaundice—Capecitabine—colon cancer	0.000319	0.00829	CcSEcCtD
Pitavastatin—Confusional state—Irinotecan—colon cancer	0.000314	0.00817	CcSEcCtD
Pitavastatin—Myalgia—Fluorouracil—colon cancer	0.000312	0.0081	CcSEcCtD
Pitavastatin—Discomfort—Fluorouracil—colon cancer	0.000308	0.008	CcSEcCtD
Pitavastatin—Confusional state—Fluorouracil—colon cancer	0.000301	0.00783	CcSEcCtD
Pitavastatin—ABCB1—renal system—colon cancer	0.000297	0.00412	CbGeAlD
Pitavastatin—Hepatitis—Capecitabine—colon cancer	0.000294	0.00764	CcSEcCtD
Pitavastatin—Hypoaesthesia—Capecitabine—colon cancer	0.000292	0.0076	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000292	0.00758	CcSEcCtD
Pitavastatin—Insomnia—Vincristine—colon cancer	0.00029	0.00753	CcSEcCtD
Pitavastatin—Insomnia—Irinotecan—colon cancer	0.000282	0.00733	CcSEcCtD
Pitavastatin—ABCG2—lymph node—colon cancer	0.000282	0.00391	CbGeAlD
Pitavastatin—Fatigue—Vincristine—colon cancer	0.000276	0.00718	CcSEcCtD
Pitavastatin—Dyspepsia—Irinotecan—colon cancer	0.000275	0.00714	CcSEcCtD
Pitavastatin—Constipation—Vincristine—colon cancer	0.000274	0.00712	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000272	0.00707	CcSEcCtD
Pitavastatin—Insomnia—Fluorouracil—colon cancer	0.00027	0.00702	CcSEcCtD
Pitavastatin—Fatigue—Irinotecan—colon cancer	0.000269	0.00699	CcSEcCtD
Pitavastatin—Constipation—Irinotecan—colon cancer	0.000267	0.00693	CcSEcCtD
Pitavastatin—Dyspepsia—Fluorouracil—colon cancer	0.000263	0.00683	CcSEcCtD
Pitavastatin—Abdominal discomfort—Methotrexate—colon cancer	0.000262	0.00681	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Vincristine—colon cancer	0.000262	0.00681	CcSEcCtD
Pitavastatin—Feeling abnormal—Irinotecan—colon cancer	0.000257	0.00668	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Irinotecan—colon cancer	0.000255	0.00663	CcSEcCtD
Pitavastatin—Abdominal pain—Vincristine—colon cancer	0.000253	0.00658	CcSEcCtD
Pitavastatin—Erectile dysfunction—Methotrexate—colon cancer	0.000252	0.00654	CcSEcCtD
Pitavastatin—ABCG2—Fluoropyrimidine Activity—TYMS—colon cancer	0.00025	0.00958	CbGpPWpGaD
Pitavastatin—Back pain—Capecitabine—colon cancer	0.000247	0.00643	CcSEcCtD
Pitavastatin—Abdominal pain—Irinotecan—colon cancer	0.000247	0.00641	CcSEcCtD
Pitavastatin—ABCB1—lymphoid tissue—colon cancer	0.000246	0.00342	CbGeAlD
Pitavastatin—Feeling abnormal—Fluorouracil—colon cancer	0.000246	0.0064	CcSEcCtD
Pitavastatin—Muscle spasms—Capecitabine—colon cancer	0.000246	0.00639	CcSEcCtD
Pitavastatin—ABCB1—digestive system—colon cancer	0.000243	0.00338	CbGeAlD
Pitavastatin—Ill-defined disorder—Capecitabine—colon cancer	0.000237	0.00617	CcSEcCtD
Pitavastatin—Urticaria—Fluorouracil—colon cancer	0.000237	0.00617	CcSEcCtD
Pitavastatin—Hypersensitivity—Vincristine—colon cancer	0.000236	0.00613	CcSEcCtD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.000234	0.00898	CbGpPWpGaD
Pitavastatin—Malaise—Capecitabine—colon cancer	0.000231	0.00599	CcSEcCtD
Pitavastatin—Hypersensitivity—Irinotecan—colon cancer	0.00023	0.00597	CcSEcCtD
Pitavastatin—Asthenia—Vincristine—colon cancer	0.00023	0.00597	CcSEcCtD
Pitavastatin—ABCB1—bone marrow—colon cancer	0.000224	0.00311	CbGeAlD
Pitavastatin—Asthenia—Irinotecan—colon cancer	0.000224	0.00582	CcSEcCtD
Pitavastatin—Hypersensitivity—Fluorouracil—colon cancer	0.00022	0.00572	CcSEcCtD
Pitavastatin—Diarrhoea—Vincristine—colon cancer	0.000219	0.0057	CcSEcCtD
Pitavastatin—Hepatitis—Methotrexate—colon cancer	0.000219	0.00568	CcSEcCtD
Pitavastatin—Arthralgia—Capecitabine—colon cancer	0.000218	0.00566	CcSEcCtD
Pitavastatin—Myalgia—Capecitabine—colon cancer	0.000218	0.00566	CcSEcCtD
Pitavastatin—Discomfort—Capecitabine—colon cancer	0.000215	0.00559	CcSEcCtD
Pitavastatin—ABCB1—vagina—colon cancer	0.000215	0.00298	CbGeAlD
Pitavastatin—Diarrhoea—Irinotecan—colon cancer	0.000213	0.00555	CcSEcCtD
Pitavastatin—Dizziness—Vincristine—colon cancer	0.000212	0.0055	CcSEcCtD
Pitavastatin—Pruritus—Fluorouracil—colon cancer	0.000211	0.00549	CcSEcCtD
Pitavastatin—Confusional state—Capecitabine—colon cancer	0.00021	0.00547	CcSEcCtD
Pitavastatin—Dizziness—Irinotecan—colon cancer	0.000206	0.00536	CcSEcCtD
Pitavastatin—HMGCR—SREBP signalling—PPARG—colon cancer	0.000205	0.00787	CbGpPWpGaD
Pitavastatin—Diarrhoea—Fluorouracil—colon cancer	0.000204	0.00531	CcSEcCtD
Pitavastatin—Rash—Vincristine—colon cancer	0.000202	0.00525	CcSEcCtD
Pitavastatin—Dermatitis—Vincristine—colon cancer	0.000202	0.00524	CcSEcCtD
Pitavastatin—Headache—Vincristine—colon cancer	0.000201	0.00521	CcSEcCtD
Pitavastatin—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	0.0002	0.00766	CbGpPWpGaD
Pitavastatin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000199	0.00762	CbGpPWpGaD
Pitavastatin—Dizziness—Fluorouracil—colon cancer	0.000198	0.00513	CcSEcCtD
Pitavastatin—Rash—Irinotecan—colon cancer	0.000197	0.00511	CcSEcCtD
Pitavastatin—Dermatitis—Irinotecan—colon cancer	0.000196	0.00511	CcSEcCtD
Pitavastatin—Headache—Irinotecan—colon cancer	0.000195	0.00508	CcSEcCtD
Pitavastatin—Nausea—Vincristine—colon cancer	0.00019	0.00494	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00019	0.00494	CcSEcCtD
Pitavastatin—Insomnia—Capecitabine—colon cancer	0.000189	0.00491	CcSEcCtD
Pitavastatin—Rash—Fluorouracil—colon cancer	0.000188	0.0049	CcSEcCtD
Pitavastatin—Dermatitis—Fluorouracil—colon cancer	0.000188	0.00489	CcSEcCtD
Pitavastatin—Headache—Fluorouracil—colon cancer	0.000187	0.00486	CcSEcCtD
Pitavastatin—SLC10A1—Metabolism—CA7—colon cancer	0.000186	0.00714	CbGpPWpGaD
Pitavastatin—Nausea—Irinotecan—colon cancer	0.000185	0.00481	CcSEcCtD
Pitavastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—colon cancer	0.000185	0.00711	CbGpPWpGaD
Pitavastatin—Back pain—Methotrexate—colon cancer	0.000184	0.00479	CcSEcCtD
Pitavastatin—Dyspepsia—Capecitabine—colon cancer	0.000184	0.00478	CcSEcCtD
Pitavastatin—ABCB1—liver—colon cancer	0.000181	0.00252	CbGeAlD
Pitavastatin—Fatigue—Capecitabine—colon cancer	0.00018	0.00468	CcSEcCtD
Pitavastatin—Constipation—Capecitabine—colon cancer	0.000178	0.00464	CcSEcCtD
Pitavastatin—Nausea—Fluorouracil—colon cancer	0.000177	0.00461	CcSEcCtD
Pitavastatin—Ill-defined disorder—Methotrexate—colon cancer	0.000177	0.00459	CcSEcCtD
Pitavastatin—Feeling abnormal—Capecitabine—colon cancer	0.000172	0.00447	CcSEcCtD
Pitavastatin—Malaise—Methotrexate—colon cancer	0.000172	0.00446	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Capecitabine—colon cancer	0.000171	0.00444	CcSEcCtD
Pitavastatin—Urticaria—Capecitabine—colon cancer	0.000166	0.00431	CcSEcCtD
Pitavastatin—Abdominal pain—Capecitabine—colon cancer	0.000165	0.00429	CcSEcCtD
Pitavastatin—Myalgia—Methotrexate—colon cancer	0.000162	0.00421	CcSEcCtD
Pitavastatin—Arthralgia—Methotrexate—colon cancer	0.000162	0.00421	CcSEcCtD
Pitavastatin—Discomfort—Methotrexate—colon cancer	0.00016	0.00416	CcSEcCtD
Pitavastatin—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	0.000157	0.00603	CbGpPWpGaD
Pitavastatin—Confusional state—Methotrexate—colon cancer	0.000157	0.00407	CcSEcCtD
Pitavastatin—Hypersensitivity—Capecitabine—colon cancer	0.000154	0.004	CcSEcCtD
Pitavastatin—HMGCR—Metabolism—CA7—colon cancer	0.000152	0.00582	CbGpPWpGaD
Pitavastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.000151	0.00581	CbGpPWpGaD
Pitavastatin—Asthenia—Capecitabine—colon cancer	0.00015	0.00389	CcSEcCtD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—BAX—colon cancer	0.000149	0.00572	CbGpPWpGaD
Pitavastatin—Pruritus—Capecitabine—colon cancer	0.000148	0.00384	CcSEcCtD
Pitavastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.000147	0.00565	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—ABCB1—colon cancer	0.000146	0.0056	CbGpPWpGaD
Pitavastatin—Diarrhoea—Capecitabine—colon cancer	0.000143	0.00371	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000142	0.00368	CcSEcCtD
Pitavastatin—HMGCR—PPARA activates gene expression—PPARG—colon cancer	0.000141	0.00542	CbGpPWpGaD
Pitavastatin—HMGCR—AMPK Signaling—CDKN1A—colon cancer	0.000141	0.00541	CbGpPWpGaD
Pitavastatin—Insomnia—Methotrexate—colon cancer	0.000141	0.00365	CcSEcCtD
Pitavastatin—ABCB1—lymph node—colon cancer	0.000139	0.00193	CbGeAlD
Pitavastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	0.000138	0.0053	CbGpPWpGaD
Pitavastatin—Dizziness—Capecitabine—colon cancer	0.000138	0.00359	CcSEcCtD
Pitavastatin—Dyspepsia—Methotrexate—colon cancer	0.000137	0.00356	CcSEcCtD
Pitavastatin—HMGCR—TOR Signaling—AKT1—colon cancer	0.000136	0.00524	CbGpPWpGaD
Pitavastatin—Fatigue—Methotrexate—colon cancer	0.000134	0.00348	CcSEcCtD
Pitavastatin—Rash—Capecitabine—colon cancer	0.000132	0.00342	CcSEcCtD
Pitavastatin—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000132	0.00505	CbGpPWpGaD
Pitavastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	0.000131	0.00505	CbGpPWpGaD
Pitavastatin—Dermatitis—Capecitabine—colon cancer	0.000131	0.00342	CcSEcCtD
Pitavastatin—Headache—Capecitabine—colon cancer	0.000131	0.0034	CcSEcCtD
Pitavastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	0.000129	0.00495	CbGpPWpGaD
Pitavastatin—Feeling abnormal—Methotrexate—colon cancer	0.000128	0.00333	CcSEcCtD
Pitavastatin—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	0.000128	0.00491	CbGpPWpGaD
Pitavastatin—Gastrointestinal pain—Methotrexate—colon cancer	0.000127	0.0033	CcSEcCtD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.000126	0.00485	CbGpPWpGaD
Pitavastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000125	0.00481	CbGpPWpGaD
Pitavastatin—Nausea—Capecitabine—colon cancer	0.000124	0.00322	CcSEcCtD
Pitavastatin—UGT1A3—Metabolism—CA7—colon cancer	0.000124	0.00474	CbGpPWpGaD
Pitavastatin—Urticaria—Methotrexate—colon cancer	0.000123	0.00321	CcSEcCtD
Pitavastatin—Abdominal pain—Methotrexate—colon cancer	0.000123	0.00319	CcSEcCtD
Pitavastatin—SLCO1B3—Metabolism—CA7—colon cancer	0.000116	0.00447	CbGpPWpGaD
Pitavastatin—Hypersensitivity—Methotrexate—colon cancer	0.000114	0.00298	CcSEcCtD
Pitavastatin—ABCG2—HIF-2-alpha transcription factor network—EP300—colon cancer	0.000113	0.00433	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—ODC1—colon cancer	0.000113	0.00432	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CHST5—colon cancer	0.000113	0.00432	CbGpPWpGaD
Pitavastatin—Asthenia—Methotrexate—colon cancer	0.000111	0.0029	CcSEcCtD
Pitavastatin—Pruritus—Methotrexate—colon cancer	0.00011	0.00286	CcSEcCtD
Pitavastatin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—colon cancer	0.000107	0.00411	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000107	0.0041	CbGpPWpGaD
Pitavastatin—Diarrhoea—Methotrexate—colon cancer	0.000106	0.00276	CcSEcCtD
Pitavastatin—UGT2B7—Metabolism—CA7—colon cancer	0.000105	0.00403	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000104	0.00401	CbGpPWpGaD
Pitavastatin—Dizziness—Methotrexate—colon cancer	0.000103	0.00267	CcSEcCtD
Pitavastatin—HMGCR—SREBP signalling—PIK3CA—colon cancer	9.92e-05	0.00381	CbGpPWpGaD
Pitavastatin—HMGCR—AMPK Signaling—PIK3CA—colon cancer	9.92e-05	0.00381	CbGpPWpGaD
Pitavastatin—Rash—Methotrexate—colon cancer	9.8e-05	0.00255	CcSEcCtD
Pitavastatin—Dermatitis—Methotrexate—colon cancer	9.79e-05	0.00254	CcSEcCtD
Pitavastatin—Headache—Methotrexate—colon cancer	9.73e-05	0.00253	CcSEcCtD
Pitavastatin—HMGCR—AMPK Signaling—TP53—colon cancer	9.6e-05	0.00368	CbGpPWpGaD
Pitavastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	9.52e-05	0.00365	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	9.41e-05	0.00361	CbGpPWpGaD
Pitavastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	9.33e-05	0.00358	CbGpPWpGaD
Pitavastatin—HMGCR—PPARA activates gene expression—EP300—colon cancer	9.24e-05	0.00355	CbGpPWpGaD
Pitavastatin—Nausea—Methotrexate—colon cancer	9.23e-05	0.0024	CcSEcCtD
Pitavastatin—HMGCR—Metabolism—ODC1—colon cancer	9.19e-05	0.00353	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CHST5—colon cancer	9.19e-05	0.00353	CbGpPWpGaD
Pitavastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	9.04e-05	0.00347	CbGpPWpGaD
Pitavastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	8.72e-05	0.00335	CbGpPWpGaD
Pitavastatin—ABCG2—Fluoropyrimidine Activity—TP53—colon cancer	8.28e-05	0.00318	CbGpPWpGaD
Pitavastatin—HMGCR—AMPK Signaling—AKT1—colon cancer	8.11e-05	0.00311	CbGpPWpGaD
Pitavastatin—HMGCR—SREBP signalling—AKT1—colon cancer	8.11e-05	0.00311	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—CASP3—colon cancer	8e-05	0.00307	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CA7—colon cancer	7.83e-05	0.003	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—CCND1—colon cancer	7.79e-05	0.00299	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	7.71e-05	0.00296	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ODC1—colon cancer	7.49e-05	0.00287	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CHST5—colon cancer	7.49e-05	0.00287	CbGpPWpGaD
Pitavastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	7.35e-05	0.00282	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CA7—colon cancer	7.25e-05	0.00278	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—EP300—colon cancer	7.17e-05	0.00275	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ODC1—colon cancer	7.06e-05	0.00271	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CHST5—colon cancer	7.06e-05	0.00271	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	6.79e-05	0.00261	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	6.64e-05	0.00255	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	6.42e-05	0.00246	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CHST5—colon cancer	6.37e-05	0.00244	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ODC1—colon cancer	6.37e-05	0.00244	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	6.29e-05	0.00242	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—colon cancer	6.25e-05	0.0024	CbGpPWpGaD
Pitavastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	6.23e-05	0.00239	CbGpPWpGaD
Pitavastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	6.19e-05	0.00238	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—colon cancer	6.11e-05	0.00235	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—KRAS—colon cancer	5.77e-05	0.00222	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	5.4e-05	0.00207	CbGpPWpGaD
Pitavastatin—UGT1A3—NRF2 pathway—TGFB1—colon cancer	5.22e-05	0.002	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—colon cancer	5.13e-05	0.00197	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—ABCB1—colon cancer	5.1e-05	0.00196	CbGpPWpGaD
Pitavastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	5.04e-05	0.00193	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ODC1—colon cancer	4.74e-05	0.00182	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CHST5—colon cancer	4.74e-05	0.00182	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.65e-05	0.00179	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CA7—colon cancer	4.5e-05	0.00173	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CA7—colon cancer	4.47e-05	0.00172	CbGpPWpGaD
Pitavastatin—UGT2B7—NRF2 pathway—TGFB1—colon cancer	4.44e-05	0.0017	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ODC1—colon cancer	4.39e-05	0.00168	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CHST5—colon cancer	4.39e-05	0.00168	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—colon cancer	4.33e-05	0.00166	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	4.32e-05	0.00166	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	4.01e-05	0.00154	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—ABCB1—colon cancer	3.98e-05	0.00153	CbGpPWpGaD
Pitavastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	3.97e-05	0.00152	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CA7—colon cancer	3.92e-05	0.0015	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	3.92e-05	0.0015	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.79e-05	0.00146	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CA7—colon cancer	3.66e-05	0.0014	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.66e-05	0.0014	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	3.59e-05	0.00138	CbGpPWpGaD
Pitavastatin—ABCC2—NRF2 pathway—TGFB1—colon cancer	3.52e-05	0.00135	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CASP3—colon cancer	3.47e-05	0.00133	CbGpPWpGaD
Pitavastatin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	3.43e-05	0.00132	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	3.4e-05	0.00131	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—VEGFA—colon cancer	3.33e-05	0.00128	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	3.31e-05	0.00127	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	3.19e-05	0.00122	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	3.17e-05	0.00122	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—TGFB1—colon cancer	3.06e-05	0.00117	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.04e-05	0.00117	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.98e-05	0.00114	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—ABCB1—colon cancer	2.98e-05	0.00114	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—VEGFA—colon cancer	2.95e-05	0.00113	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—TP53—colon cancer	2.93e-05	0.00113	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—TYMS—colon cancer	2.92e-05	0.00112	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.91e-05	0.00112	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	2.91e-05	0.00112	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.85e-05	0.00109	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ODC1—colon cancer	2.72e-05	0.00105	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CHST5—colon cancer	2.72e-05	0.00105	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ODC1—colon cancer	2.71e-05	0.00104	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CHST5—colon cancer	2.71e-05	0.00104	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—TGFB1—colon cancer	2.7e-05	0.00104	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	2.67e-05	0.00103	CbGpPWpGaD
Pitavastatin—Atorvastatin—ABCB1—colon cancer	2.66e-05	1	CrCbGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.48e-05	0.000952	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.48e-05	0.000951	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.43e-05	0.000933	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ABCB1—colon cancer	2.43e-05	0.000932	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—TYMS—colon cancer	2.38e-05	0.000915	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ODC1—colon cancer	2.37e-05	0.000911	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CHST5—colon cancer	2.37e-05	0.000911	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.29e-05	0.00088	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.25e-05	0.000864	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ODC1—colon cancer	2.22e-05	0.000851	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CHST5—colon cancer	2.22e-05	0.000851	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.17e-05	0.000833	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PPARG—colon cancer	2.07e-05	0.000795	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ABCB1—colon cancer	1.98e-05	0.000759	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.96e-05	0.000751	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—TYMS—colon cancer	1.94e-05	0.000746	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.91e-05	0.000731	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ABCB1—colon cancer	1.86e-05	0.000716	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.85e-05	0.000708	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.84e-05	0.000704	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—TYMS—colon cancer	1.83e-05	0.000703	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.71e-05	0.000658	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PPARG—colon cancer	1.69e-05	0.000648	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ABCB1—colon cancer	1.68e-05	0.000646	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.67e-05	0.00064	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—TYMS—colon cancer	1.65e-05	0.000634	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.65e-05	0.000634	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTGS2—colon cancer	1.63e-05	0.000625	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.61e-05	0.000619	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.54e-05	0.000591	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.54e-05	0.000589	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	1.53e-05	0.000587	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	1.52e-05	0.000582	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.49e-05	0.000573	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	1.48e-05	0.000567	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.45e-05	0.000558	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.41e-05	0.000541	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PPARG—colon cancer	1.38e-05	0.000528	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—EP300—colon cancer	1.36e-05	0.00052	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	1.36e-05	0.00052	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.34e-05	0.000513	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.33e-05	0.000512	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTGS2—colon cancer	1.33e-05	0.00051	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.31e-05	0.000502	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PPARG—colon cancer	1.3e-05	0.000498	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.28e-05	0.000491	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ABCB1—colon cancer	1.25e-05	0.000481	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.24e-05	0.000474	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—TYMS—colon cancer	1.23e-05	0.000472	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PPARG—colon cancer	1.17e-05	0.000449	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ABCB1—colon cancer	1.16e-05	0.000445	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	1.15e-05	0.000443	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—TYMS—colon cancer	1.14e-05	0.000437	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.14e-05	0.000436	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.12e-05	0.000432	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.12e-05	0.000429	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—EP300—colon cancer	1.1e-05	0.000424	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.1e-05	0.000422	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTGS2—colon cancer	1.08e-05	0.000416	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTGS2—colon cancer	1.02e-05	0.000392	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PIK3CA—colon cancer	1e-05	0.000385	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.47e-06	0.000364	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	9.42e-06	0.000362	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	9.28e-06	0.000356	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTGS2—colon cancer	9.21e-06	0.000353	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.15e-06	0.000351	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—EP300—colon cancer	9.01e-06	0.000346	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.85e-06	0.00034	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.8e-06	0.000338	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPARG—colon cancer	8.72e-06	0.000335	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—EP300—colon cancer	8.49e-06	0.000326	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AKT1—colon cancer	8.19e-06	0.000314	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CA—colon cancer	8.17e-06	0.000314	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPARG—colon cancer	8.07e-06	0.00031	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—EP300—colon cancer	8.04e-06	0.000308	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SRC—colon cancer	7.81e-06	0.0003	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—EP300—colon cancer	7.66e-06	0.000294	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—colon cancer	7.61e-06	0.000292	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NRAS—colon cancer	7.52e-06	0.000289	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.36e-06	0.000282	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.32e-06	0.000281	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.2e-06	0.000276	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ABCB1—colon cancer	7.2e-06	0.000276	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ABCB1—colon cancer	7.16e-06	0.000275	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—TYMS—colon cancer	7.07e-06	0.000271	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—TYMS—colon cancer	7.03e-06	0.00027	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TGFB1—colon cancer	6.99e-06	0.000268	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTGS2—colon cancer	6.86e-06	0.000263	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKT1—colon cancer	6.68e-06	0.000256	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CA—colon cancer	6.66e-06	0.000256	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—KRAS—colon cancer	6.47e-06	0.000248	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTGS2—colon cancer	6.35e-06	0.000244	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CA—colon cancer	6.28e-06	0.000241	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—TYMS—colon cancer	6.16e-06	0.000236	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.99e-06	0.00023	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CA—colon cancer	5.94e-06	0.000228	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ABCB1—colon cancer	5.86e-06	0.000225	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—TYMS—colon cancer	5.75e-06	0.000221	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—colon cancer	5.75e-06	0.000221	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—EP300—colon cancer	5.7e-06	0.000219	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CA—colon cancer	5.67e-06	0.000217	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—HRAS—colon cancer	5.5e-06	0.000211	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.44e-06	0.000209	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKT1—colon cancer	5.44e-06	0.000209	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.41e-06	0.000208	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—EP300—colon cancer	5.28e-06	0.000203	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKT1—colon cancer	5.13e-06	0.000197	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPARG—colon cancer	5.01e-06	0.000192	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPARG—colon cancer	4.98e-06	0.000191	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—AKT1—colon cancer	4.86e-06	0.000186	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKT1—colon cancer	4.63e-06	0.000178	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.43e-06	0.00017	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPARG—colon cancer	4.36e-06	0.000167	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CA—colon cancer	4.22e-06	0.000162	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPARG—colon cancer	4.08e-06	0.000156	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTGS2—colon cancer	3.94e-06	0.000151	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTGS2—colon cancer	3.92e-06	0.00015	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CA—colon cancer	3.91e-06	0.00015	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKT1—colon cancer	3.45e-06	0.000132	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTGS2—colon cancer	3.43e-06	0.000132	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—EP300—colon cancer	3.28e-06	0.000126	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—EP300—colon cancer	3.26e-06	0.000125	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTGS2—colon cancer	3.21e-06	0.000123	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKT1—colon cancer	3.19e-06	0.000122	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—EP300—colon cancer	2.85e-06	0.00011	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—EP300—colon cancer	2.67e-06	0.000102	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CA—colon cancer	2.42e-06	9.3e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CA—colon cancer	2.41e-06	9.25e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CA—colon cancer	2.11e-06	8.11e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKT1—colon cancer	1.98e-06	7.6e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CA—colon cancer	1.97e-06	7.57e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKT1—colon cancer	1.97e-06	7.56e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKT1—colon cancer	1.73e-06	6.62e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKT1—colon cancer	1.61e-06	6.19e-05	CbGpPWpGaD
